— Know what they know.
Not Investment Advice

CVRX NASDAQ

CVRx, Inc.
1W: +5.8% 1M: -23.9% 3M: -0.7% YTD: -14.5% 1Y: -13.2% 3Y: -50.0%
$6.11
+0.04 (+0.66%)
 
Weekly Expected Move ±16.7%
$4 $5 $6 $7 $8
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Sell · Power 33 · $162.1M mcap · 18M float · 1.80% daily turnover · Short 56% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
56.8 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -274.1%  ·  5Y Avg: -115.2%
Cost Advantage
38
Intangibles
81
Switching Cost
48
Network Effect
78
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CVRX has a Narrow competitive edge (56.8/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Intangible Assets. Negative ROIC of -274.1% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$12
Avg Target
$12
High
Based on 2 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 6Hold: 0Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$11.50
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-02-13 Canaccord Genuity William Plovanic $15 $10 -5 +75.7% $5.69
2025-11-06 Cantor Fitzgerald Ross Osborn $14 $13 -1 +30.3% $9.98
2024-10-30 Piper Sandler Matt O'Brien $13 $16 +3 +24.0% $12.90
2024-09-10 Cantor Fitzgerald Ross Osborn Initiated $14 +75.9% $7.96
2024-07-30 Piper Sandler Matt O'Brien Initiated $13 +40.2% $9.27
2024-07-30 Canaccord Genuity William Plovanic Initiated $15 +61.8% $9.27
2024-07-11 Lake Street Frank Takkinen Initiated $12 +58.1% $7.59
2024-06-05 Loop Capital Markets Frank Takkinen Initiated $18 +125.1% $8.00
2024-05-01 Craig-Hallum Chase Knickerbocker Initiated $23 +148.1% $9.27

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CVRX receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-01-03 C- D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

24 Grade D
Profitability
20
Balance Sheet
43
Earnings Quality
42
Growth
58
Value
24
Momentum
56
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CVRX scores highest in Growth (58/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-5.52
Distress Zone
Piotroski F-Score
3/9
Beneish M-Score
-2.92
Unlikely Manipulator
Ohlson O-Score
-3.68
Bankruptcy prob: 2.5%
Low Risk
Credit Rating
B
Score: 27.7/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.75x
Accruals: -11.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CVRX scores -5.52, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CVRX scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CVRX's score of -2.92 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CVRX's implied 2.5% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CVRX receives an estimated rating of B (score: 27.7/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-3.09x
PEG
-0.41x
P/S
2.78x
P/B
5.60x
P/FCF
-6.21x
P/OCF
EV/EBITDA
-4.80x
EV/Revenue
3.80x
EV/EBIT
-4.74x
EV/FCF
-5.59x
Earnings Yield
-21.12%
FCF Yield
-16.11%
Shareholder Yield
0.02%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CVRX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.113
EBT / EBIT
×
EBIT Margin
-0.801
EBIT / Rev
×
Asset Turnover
0.496
Rev / Assets
×
Equity Multiplier
2.158
Assets / Equity
=
ROE
-95.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CVRX's ROE of -95.4% is driven by Asset Turnover (0.496), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1230 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$6.11
Median 1Y
$2.75
5th Pctile
$0.60
95th Pctile
$12.70
Ann. Volatility
98.6%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Philip Adamson Medical
edical Officer
$549,539 $259,200 $1,361,143

CEO Pay Ratio

23:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $9,082,769
Avg Employee Cost (SGA/emp): $396,740
Employees: 223

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
223
+8.2% YoY
Revenue / Employee
$254,040
Rev: $56,651,000
Profit / Employee
$-239,040
NI: $-53,306,000
SGA / Employee
$396,740
Avg labor cost proxy
R&D / Employee
$49,919
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 6.1% 8.1% -23.6% -30.4% 51.3% 56.3% -32.5% -33.6% -34.0% -33.4% -44.5% -56.2% -58.8% -63.2% -81.6% -70.1% -71.1% -70.8% -96.6% -95.4% -95.42%
ROA -27.4% -36.9% -22.6% -29.1% -34.8% -38.2% -29.9% -30.9% -31.3% -30.7% -34.3% -43.3% -45.3% -48.7% -48.2% -41.5% -42.0% -41.8% -44.8% -44.2% -44.21%
ROIC 1.3% 3.1% -4.4% -6.4% -7.5% -8.1% -3.3% -3.5% -3.6% -3.5% -2.1% -2.6% -2.7% -2.9% -3.0% -2.6% -2.6% -2.6% -2.8% -2.7% -2.74%
ROCE -30.1% -39.8% -22.3% -29.1% -25.0% -27.9% -35.2% -36.2% -36.3% -35.1% -36.6% -46.0% -47.7% -51.1% -45.3% -38.0% -38.2% -37.6% -51.9% -51.8% -51.76%
Gross Margin 70.8% 74.2% 73.1% 76.7% 76.1% 78.3% 79.0% 83.4% 84.0% 83.9% 84.8% 83.8% 82.7% 83.2% 85.0% 83.5% 84.3% 86.8% 86.3% 87.2% 87.22%
Operating Margin -1.8% -2.1% -2.4% -2.4% -2.2% -1.6% -1.6% -1.5% -1.2% -90.6% -85.5% -2.1% -1.2% -97.3% -67.0% -1.1% -1.1% -83.5% -69.8% -82.3% -82.34%
Net Margin -5.7% -1.8% -2.9% -2.5% -2.2% -1.6% -1.5% -1.4% -1.2% -85.7% -81.1% -2.1% -1.2% -98.0% -69.4% -1.1% -1.1% -87.6% -74.5% -88.8% -88.83%
EBITDA Margin -5.5% -1.6% -2.8% -2.4% -2.2% -1.6% -1.4% -1.4% -1.2% -79.3% -74.4% -2.0% -1.1% -89.2% -58.8% -98.2% -96.2% -76.2% -64.5% -82.3% -82.34%
FCF Margin -2.2% -2.5% -2.3% -2.4% -2.4% -2.1% -1.9% -1.6% -1.5% -1.2% -1.0% -97.3% -86.0% -85.6% -79.0% -78.6% -72.1% -69.7% -71.9% -68.0% -67.98%
OCF Margin -2.1% -2.4% -2.2% -2.3% -2.3% -2.1% -1.9% -1.6% -1.5% -1.2% -99.3% -94.3% -82.6% -82.5% -76.3% -77.6% -71.6% -68.6% -70.9% -67.0% -66.98%
ROE 3Y Avg snapshot only -91.65%
ROE 5Y Avg snapshot only -68.92%
ROA 3Y Avg snapshot only -44.67%
ROIC 3Y Avg snapshot only -1.48%
ROIC Economic snapshot only -44.41%
Cash ROA snapshot only -37.76%
Cash ROIC snapshot only -2.75%
CROIC snapshot only -2.79%
NOPAT Margin snapshot only -66.85%
Pretax Margin snapshot only -89.17%
R&D / Revenue snapshot only 19.80%
SGA / Revenue snapshot only 1.51%
SBC / Revenue snapshot only 9.66%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -0.58 -13.94 -7.23 -2.76 -3.26 -4.63 -9.12 -4.50 -7.37 -7.41 -15.89 -7.43 -4.77 -3.43 -4.77 -6.14 -2.93 -4.06 -3.49 -4.73 -3.093
P/S Ratio 3.28 51.07 24.48 8.60 7.63 10.13 16.82 7.31 10.37 8.97 16.66 9.19 5.84 4.25 5.58 5.99 2.81 3.77 3.29 4.22 2.776
P/B Ratio -0.03 -1.14 1.71 0.84 0.84 1.32 3.46 1.77 2.93 2.89 8.62 5.09 3.41 2.64 4.03 4.45 2.16 2.97 4.73 6.34 5.595
P/FCF -1.50 -20.52 -10.48 -3.53 -3.24 -4.80 -8.71 -4.49 -6.99 -7.42 -16.53 -9.44 -6.79 -4.96 -7.07 -7.61 -3.89 -5.42 -4.57 -6.21 -6.209
P/OCF
EV/EBITDA 1.73 -13.01 -3.28 0.46 0.52 -1.23 -6.84 -2.24 -5.27 -5.34 -15.36 -6.69 -3.93 -2.59 -4.20 -5.68 -2.12 -3.43 -3.45 -4.80 -4.798
EV/Revenue -9.47 44.96 10.52 -1.37 -1.17 2.63 12.41 3.56 7.16 6.16 15.14 7.76 4.49 2.98 4.50 4.94 1.79 2.78 2.85 3.80 3.799
EV/EBIT 1.73 -12.96 -3.27 0.46 0.51 -1.22 -6.77 -2.22 -5.21 -5.27 -15.15 -6.62 -3.89 -2.57 -4.16 -5.60 -2.09 -3.37 -3.39 -4.74 -4.740
EV/FCF 4.32 -18.06 -4.50 0.56 0.50 -1.25 -6.43 -2.18 -4.83 -5.09 -15.02 -7.98 -5.22 -3.48 -5.70 -6.28 -2.48 -3.99 -3.96 -5.59 -5.588
Earnings Yield -1.7% -7.2% -13.8% -36.3% -30.6% -21.6% -11.0% -22.2% -13.6% -13.5% -6.3% -13.5% -21.0% -29.1% -20.9% -16.3% -34.1% -24.6% -28.6% -21.1% -21.12%
FCF Yield -66.8% -4.9% -9.5% -28.3% -30.8% -20.8% -11.5% -22.3% -14.3% -13.5% -6.0% -10.6% -14.7% -20.2% -14.1% -13.1% -25.7% -18.5% -21.9% -16.1% -16.11%
Price/Tangible Book snapshot only 6.340
EV/Gross Profit snapshot only 4.408
Shareholder Yield snapshot only 0.02%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 8.07 8.07 25.57 25.57 25.57 25.57 15.19 15.19 15.19 15.19 14.25 14.25 14.25 14.25 12.06 12.06 12.06 12.06 7.63 7.63 7.633
Quick Ratio 7.65 7.65 24.92 24.92 24.92 24.92 14.33 14.33 14.33 14.33 12.86 12.86 12.86 12.86 10.94 10.94 10.94 10.94 6.72 6.72 6.716
Debt/Equity -0.07 -0.07 0.00 0.00 0.00 0.00 0.06 0.06 0.06 0.06 0.40 0.40 0.40 0.40 0.71 0.71 0.71 0.71 1.29 1.29 1.292
Net Debt/Equity -0.97 -0.97 -0.97 -0.97 -0.91 -0.91 -0.91 -0.91 -0.79 -0.79 -0.79 -0.79 -0.78 -0.78 -0.78 -0.78 -0.63 -0.63 -0.634
Debt/Assets 0.30 0.30 0.00 0.00 0.00 0.00 0.06 0.06 0.06 0.06 0.27 0.27 0.27 0.27 0.38 0.38 0.38 0.38 0.48 0.48 0.485
Debt/EBITDA -1.13 -0.86 -0.00 -0.00 -0.00 -0.00 -0.17 -0.17 -0.17 -0.17 -0.79 -0.63 -0.60 -0.56 -0.92 -1.10 -1.09 -1.11 -1.09 -1.09 -1.086
Net Debt/EBITDA 2.33 1.77 4.35 3.34 3.90 3.50 2.43 2.37 2.37 2.45 1.55 1.23 1.18 1.10 1.01 1.21 1.20 1.22 0.53 0.53 0.533
Interest Coverage -28.15 -18.50 -20.25 -26.41 -36.30 -103.43 -249.42 -104.42 -47.83 -29.64 -21.82 -19.59 -17.10 -15.87 -12.63 -9.53 -8.67 -7.79 -8.15 -8.00 -7.996
Equity Multiplier -0.22 -0.22 1.05 1.05 1.05 1.05 1.14 1.14 1.14 1.14 1.52 1.52 1.52 1.52 1.88 1.88 1.88 1.88 2.66 2.66 2.665
Cash Ratio snapshot only 5.685
Debt Service Coverage snapshot only -7.900
Cash to Debt snapshot only 1.491
FCF to Debt snapshot only -0.791
Defensive Interval snapshot only 312.5 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.05 0.10 0.07 0.09 0.15 0.17 0.16 0.19 0.22 0.25 0.33 0.35 0.37 0.39 0.41 0.43 0.44 0.45 0.48 0.50 0.496
Inventory Turnover 0.27 0.54 0.71 0.96 1.11 1.24 0.92 0.99 1.05 1.12 0.70 0.74 0.80 0.86 0.72 0.75 0.76 0.73 0.68 0.67 0.672
Receivables Turnover 2.44 5.09 3.98 5.57 8.41 9.87 5.57 6.54 7.65 8.72 6.02 6.45 6.80 7.24 6.10 6.29 6.50 6.66 5.68 5.93 5.927
Payables Turnover 1.89 3.70 5.44 7.30 8.08 9.01 4.49 4.83 5.11 5.42 3.47 3.70 4.00 4.30 3.73 3.86 3.91 3.77 2.59 2.54 2.545
DSO 150 72 92 66 43 37 65 56 48 42 61 57 54 50 60 58 56 55 64 62 61.6 days
DIO 1336 682 511 380 329 295 396 368 347 327 523 491 455 422 506 489 483 501 534 544 543.5 days
DPO 193 99 67 50 45 41 81 76 71 67 105 99 91 85 98 95 93 97 141 143 143.4 days
Cash Conversion Cycle 1293 655 535 396 327 291 380 348 324 302 479 449 417 388 468 452 446 459 457 462 461.7 days
Fixed Asset Turnover snapshot only 18.927
Operating Cycle snapshot only 605.1 days
Cash Velocity snapshot only 0.780
Capital Intensity snapshot only 1.774
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 4.2% 1.9% 1.2% 85.0% 90.8% 85.6% 74.9% 59.6% 43.9% 34.4% 30.5% 25.6% 23.1% 18.4% 10.4% 11.7% 11.73%
Net Income -1.1% -73.6% -20.3% 3.7% -14.9% -2.7% 0.6% -21.5% -25.3% -37.4% -45.5% 0.9% 3.9% 11.0% 11.1% -2.2% -2.16%
EPS 96.2% -69.8% -18.9% 4.8% -13.8% -1.6% 1.7% -18.4% -20.0% -25.4% -34.2% 18.7% 20.3% 22.5% 23.4% -0.3% -0.30%
FCF -4.6% -1.5% -82.4% -23.6% -20.3% -6.3% 8.6% 4.6% 16.5% 4.9% -2.3% -1.6% -3.3% 3.6% -0.6% 3.4% 3.41%
EBITDA -1.1% -80.3% -24.9% 1.7% -15.0% 0.2% 4.9% -16.8% -21.1% -33.9% -41.7% 5.8% 9.0% 16.3% 14.9% -1.8% -1.75%
Op. Income -5.5% -2.1% -95.5% -41.4% -23.0% -12.8% -1.4% -18.7% -21.7% -31.1% -38.0% 4.7% 7.8% 14.5% 13.8% 1.4% 1.39%
OCF Growth snapshot only 3.53%
Asset Growth snapshot only -21.45%
Equity Growth snapshot only -44.66%
Debt Growth snapshot only 0.71%
Shares Change snapshot only 1.85%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.4% 93.5% 71.5% 54.8% 50.1% 43.5% 36.1% 30.8% 30.84%
Revenue 5Y
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 1.6% 1.0% 79.7% 61.4% 55.8% 48.7% 40.4% 34.3% 34.35%
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 21.2% 21.2% -4.4% -4.4% -4.4% -4.4% -5.7% -5.7% -5.69%
Assets 5Y
Equity 3Y -21.3% -21.3% -21.3% -21.3% -28.9% -28.9% -28.85%
Book Value 3Y -24.0% -27.3% -27.4% -27.4% -34.4% -34.4% -34.36%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 1.00 0.99 0.99 0.99 1.00 1.00 1.00 1.00 0.99 0.98 0.95 0.96 0.963
Earnings Stability 0.90 0.79 0.72 0.59 0.94 0.92 0.81 0.69 0.85 0.78 0.74 0.72 0.724
Margin Stability 0.93 0.93 0.93 0.94 0.92 0.93 0.93 0.94 0.95 0.95 0.96 0.97 0.967
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.94 0.99 1.00 0.91 0.90 0.85 0.82 1.00 0.98 0.96 0.96 0.99 0.991
Earnings Smoothness
ROE Trend -0.23 -0.34 -0.39 -0.43 -0.38 -0.19 -0.18 -0.15 -0.66 -0.63 -0.634
Gross Margin Trend 0.09 0.08 0.09 0.07 0.05 0.04 0.03 0.02 0.01 0.02 0.01 0.02 0.023
FCF Margin Trend 0.79 1.09 1.13 1.06 1.06 0.80 0.68 0.51 0.45 0.34 0.18 0.20 0.200
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.36 0.66 0.66 0.75 0.98 0.94 1.03 0.99 1.04 0.99 0.95 0.76 0.67 0.67 0.65 0.80 0.75 0.74 0.75 0.75 0.751
FCF/OCF 1.06 1.03 1.05 1.04 1.03 1.03 1.02 1.01 1.02 1.01 1.02 1.03 1.04 1.04 1.03 1.01 1.01 1.01 1.01 1.01 1.015
FCF/Net Income snapshot only 0.763
CapEx/Revenue 12.1% 8.3% 10.6% 9.6% 6.5% 6.0% 3.0% 2.4% 2.4% 1.4% 1.5% 3.0% 3.3% 3.1% 2.7% 1.1% 0.6% 1.0% 1.0% 1.0% 1.00%
CapEx/Depreciation snapshot only 1.030
Accruals Ratio -0.17 -0.13 -0.08 -0.07 -0.01 -0.02 0.01 -0.00 0.01 -0.00 -0.02 -0.10 -0.15 -0.16 -0.17 -0.08 -0.11 -0.11 -0.11 -0.11 -0.110
Sloan Accruals snapshot only -0.263
Cash Flow Adequacy snapshot only -67.291
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.02%
Net Buyback Yield 0.0% -40.0% -53.5% -1.1% -1.1% -0.2% -0.1% -0.2% -0.2% -0.2% -0.1% -0.3% -0.2% -10.0% -11.4% -13.1% -27.4% -10.6% -5.7% -0.4% -0.36%
Total Shareholder Return 0.0% -40.0% -53.5% -1.1% -1.1% -0.2% -0.1% -0.2% -0.2% -0.2% -0.1% -0.3% -0.2% -10.0% -11.4% -13.1% -27.4% -10.6% -5.7% -0.4% -0.36%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.04 1.05 1.05 1.04 1.03 1.01 1.00 1.01 1.02 1.03 1.05 1.05 1.06 1.06 1.08 1.10 1.12 1.13 1.12 1.11 1.113
EBIT Margin -5.48 -3.47 -3.22 -3.00 -2.27 -2.16 -1.83 -1.60 -1.37 -1.17 -1.00 -1.17 -1.15 -1.16 -1.08 -0.88 -0.86 -0.83 -0.84 -0.80 -0.801
Asset Turnover 0.05 0.10 0.07 0.09 0.15 0.17 0.16 0.19 0.22 0.25 0.33 0.35 0.37 0.39 0.41 0.43 0.44 0.45 0.48 0.50 0.496
Equity Multiplier -0.22 -0.22 1.05 1.05 -1.48 -1.48 1.09 1.09 1.09 1.09 1.30 1.30 1.30 1.30 1.69 1.69 1.69 1.69 2.16 2.16 2.158
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-48.48 $-1.19 $-1.69 $-2.17 $-1.84 $-2.01 $-2.01 $-2.07 $-2.09 $-2.05 $-1.98 $-2.45 $-2.51 $-2.57 $-2.65 $-1.99 $-2.00 $-1.99 $-2.03 $-2.00 $-2.00
Book Value/Share $-801.05 $-14.57 $7.17 $7.14 $7.12 $7.09 $5.30 $5.28 $5.27 $5.25 $3.65 $3.58 $3.51 $3.33 $3.14 $2.75 $2.73 $2.72 $1.50 $1.49 $1.10
Tangible Book/Share $-801.05 $-14.57 $7.17 $7.14 $7.12 $7.09 $5.30 $5.28 $5.27 $5.25 $3.65 $3.58 $3.51 $3.33 $3.14 $2.75 $2.73 $2.72 $1.50 $1.49 $1.49
Revenue/Share $8.53 $0.32 $0.50 $0.70 $0.79 $0.92 $1.09 $1.27 $1.49 $1.69 $1.89 $1.98 $2.05 $2.07 $2.27 $2.04 $2.10 $2.14 $2.16 $2.24 $2.24
FCF/Share $-18.69 $-0.81 $-1.17 $-1.70 $-1.85 $-1.94 $-2.11 $-2.07 $-2.21 $-2.04 $-1.90 $-1.93 $-1.76 $-1.78 $-1.79 $-1.61 $-1.51 $-1.49 $-1.55 $-1.52 $-1.52
OCF/Share $-17.66 $-0.78 $-1.11 $-1.63 $-1.80 $-1.89 $-2.07 $-2.04 $-2.17 $-2.02 $-1.87 $-1.87 $-1.70 $-1.71 $-1.73 $-1.59 $-1.50 $-1.47 $-1.53 $-1.50 $-1.50
Cash/Share $161.48 $2.94 $6.98 $6.95 $6.93 $6.90 $5.16 $5.13 $5.13 $5.11 $4.35 $4.27 $4.19 $3.98 $4.69 $4.09 $4.06 $4.05 $2.89 $2.87 $2.74
EBITDA/Share $-46.65 $-1.12 $-1.60 $-2.08 $-1.78 $-1.97 $-1.98 $-2.02 $-2.02 $-1.95 $-1.86 $-2.30 $-2.34 $-2.38 $-2.43 $-1.78 $-1.77 $-1.74 $-1.78 $-1.77 $-1.77
Debt/Share $52.66 $0.96 $0.00 $0.00 $0.00 $0.00 $0.34 $0.34 $0.34 $0.34 $1.47 $1.44 $1.42 $1.34 $2.23 $1.95 $1.93 $1.93 $1.94 $1.93 $1.93
Net Debt/Share $-108.82 $-1.98 $-6.98 $-6.95 $-6.93 $-6.90 $-4.81 $-4.79 $-4.79 $-4.76 $-2.88 $-2.82 $-2.77 $-2.63 $-2.46 $-2.14 $-2.13 $-2.12 $-0.95 $-0.95 $-0.95
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -5.522
Altman Z-Prime snapshot only -11.882
Piotroski F-Score 2 2 2 2 4 4 2 3 2 3 3 3 2 2 4 4 5 5 4 3 3
Beneish M-Score -1.88 -1.79 -1.45 -1.51 -1.46 -1.58 -2.16 -2.71 -2.88 -2.96 -2.97 -2.60 -2.76 -2.78 -2.94 -2.92 -2.922
Ohlson O-Score snapshot only -3.677
ROIC (Greenblatt) snapshot only -51.77%
Net-Net WC snapshot only $1.37
EVA snapshot only $-40931910.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B
Credit Score 20.00 20.00 67.49 67.64 68.65 68.55 64.88 52.42 63.87 63.38 62.80 37.04 31.79 31.55 29.95 29.90 29.88 29.68 28.01 27.67 27.667
Credit Grade snapshot only 15
Credit Trend snapshot only -2.237
Implied Spread (bps) snapshot only 750.000
Industry Credit Rank snapshot only 18
Sector Credit Rank snapshot only 16

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms